1. Analysis of Sigma-1 Receptor Binding Ability Under Emotional Stress and Upon Administration of the Anxiolytic Afobazole

   • E. V. Abramova
   • M. V. Voronin
   • S. B. Seredenin

   MOLECULAR-BIOLOGICAL PROBLEMS OF DRUG DESIGN AND MECHANISM OF DRUG ACTION 05 December 2019 Pages: 673 - 677

   

2. Role of Drug – Drug Interactions in the Efficacy and Safety of Clarithromycin Treatment for Helicobacter Pylori Eradication

   • S. Yu. Serebrova
   • E. N. Kareva
   • A. K. Starodubtsev

   OriginalPaper 02 December 2019 Pages: 678 - 679

3. Investigation Planning and Bioequivalence evaluation of Angiotensin II Receptor Antagonists

   • D. P. Romodanovskii
   • D. V. Goryachev
   • A. N. Miroshnikov

   OriginalPaper 02 December 2019 Pages: 680 - 684

4. Elimination Half-Life of Short Peptide Drugs in Humans Extrapolated From Animal Pharmacokinetic Pharmacokinetic Studies

   • A. A. Litvin
   • R. V. Shevchenko
   • N. Yu. Ivashkina

   OriginalPaper 02 December 2019 Pages: 685 - 688

   

5. Theoretical and Experimental in vitro Antifungal and Antitumor Activities of Organotin(IV) Derivatives of 3-(4-nitrophenyl)-2-methylacrylic acid

   • Niaz Muhammad
   • Naseer Ali Shah
   • Umer Rashid

   OriginalPaper 05 December 2019 Pages: 689 - 696

   

6. Synthesis and Antitumor and Antimetastatic Activity of 5-hydroxypyrimidine Derivatives

   • S. V. Nikitin
   • L. P. Kovalenko
   • A. D. Durnev

   SEARCH FOR NEW DRUGS 05 December 2019 Pages: 697 - 700

7. Synthesis, Properties, Analgesic and Anti-Inflammatory Activity, And Hemostatic Effect of 4-Acyl-1-(2-Aminopropyl)- 5-Aryl-3-Hydroxy-3-Pyrrolin-2-Ones and their Derivatives

   • V. L. Gein
   • N. N. Kasimova
   • B. Ya. Syropyatov

   OriginalPaper 03 December 2019 Pages: 701 - 705

   

8. Synthesis and Antiproliferative Activity of Isolongifolanone Pyrazoline Derivatives Inducing Intracellular ROS Accumulation

   • Chenliang Wu
   • Yunyun Wang
   • Shifa Wang

   OriginalPaper 04 December 2019 Pages: 706 - 712

   

9. Synthesis, in Silico and in Vitro Study on Phase I Metabolism of the Potent 5-Ht7/5-Ht1a/D2 Receptor Ligand: 4-Fluoron -(1-{2-[2-(Methylsulfanyl)- Phenoxy]Ethyl}Pyrrolidin-3-Yl) Benzene Sulfonamide

   • Paulina Kubowicz-Kwaoeny
   • Kamil Piska
   • Elźbieta Pêkala

   OriginalPaper 04 December 2019 Pages: 713 - 719

   

10. New Formulation Technique for Solubility and Dissolution Rate Enhancement of Poorly Soluble Drugs

    • Divya Harmalkar
    • Soraiya Godinho
    • Rupesh Kalidas Shirodkar

    OriginalPaper 04 December 2019 Pages: 720 - 729

    

11. Design of Experiments in Pharmaceutical Development

    • Abhishek S. Dhoot
    • Gasper J. Fernandes
    • Lalit Kumar

    OriginalPaper 04 December 2019 Pages: 730 - 735

    

12. Development and Validation of an HPLC-UV Method for Arbutin Determination in Bearberry Leaves

    • A. V. Nikulin
    • M. V. Okuneva
    • O. G. Potanina

    MEDICINAL PLANTS 05 December 2019 Pages: 736 - 740

    

13. Phenolic Compounds of Endemic Buxus Plants in Caspian Hyrcanian Forest (Buxus Hyrcana Pojark) and Their Biological Activities

    • Ehsan Karimi
    • Pooyan Mehrabanjoubani
    • Jamshidkhan Chamani

    OriginalPaper 05 December 2019 Pages: 741 - 747

    

14. Development of a Pharmaceutical Composition and Stablity of Liquid Dosage Forms Based on Monoclonal IgG1 Antibodies

    • E. A. Lomkova
    • V. O. Shitikova
    • A. M. Ryakhovskaya

    DRUG SYNTHESIS METHODS AND MANUFACTURING TECHNOLOGY 05 December 2019 Pages: 748 - 754

    

15. Preparation and Properties of Lysozyme-Containing Eye Drops for Tear-Substitutive Therapy

    • I. I. Romanovskaya
    • S. S. Dekina
    • A. B. Abramova

    OriginalPaper 05 December 2019 Pages: 755 - 758

    

16. Comparison of FDA (2018) and EAEU Regulatory Requirements for Bioanalytical Method Validation

    • N. E. Uvarova
    • N. N. Eremenko
    • V. V. Smirnov

    STRUCTURE OF CHEMICAL COMPOUNDS, METHODS OF ANALYSIS AND PROCESS CONTROL 05 December 2019 Pages: 759 - 765

17. Comparison of Approaches to Determining N-Nitrosodimethylamine Impurity in Valsartan Drug Substance By GC-MS Methods

    • M. D. Khorol’skii
    • O. V. Anan’ina
    • G. V. Ramenskaya

    OriginalPaper 04 December 2019 Pages: 766 - 770

    

18. Comparison of Quantitative Analytical Techniques for Dabigatran in Blood Plasma of Humans with Knee Replacements

    • A. V. Kozlov
    • V. V. Smirnov
    • L. M. Makarenkova

    OriginalPaper 04 December 2019 Pages: 771 - 774

19. Stability Indicating RP-HPLC Method for Simultaneous Determination of Pholcodine and Guaiacol in Pharmaceutical Syrup

    • Fotouh R. Mansour
    • Mostafa A. Khairy

    OriginalPaper 04 December 2019 Pages: 775 - 779